Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth.
about
Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination StrategiesRational drug design and synthesis of molecules targeting the angiotensin II type 1 and type 2 receptorsSelf-Assembled Bifunctional Peptide as Effective Drug Delivery Vector with Powerful Antitumor Activity.Angiotensin II type 2 receptor promotes apoptosis and inhibits angiogenesis in bladder cancer.Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin.2-diethylaminoethyl-dextran methyl methacrylate copolymer nonviral vector: still a long way toward the safety of aerosol gene therapy.Effects of angiotensin II type 2 receptor overexpression on the growth of hepatocellular carcinoma cells in vitro and in vivo.G-protein coupled receptors of the renin-angiotensin system: new targets against breast cancer?Gene expression profiling associated with angiotensin II type 2 receptor-induced apoptosis in human prostate cancer cellsVectors for inhaled gene therapy in lung cancer. Application for nano oncology and safety of bio nanotechnology.Small-molecule AT2 receptor agonists.Adenovirus-Mediated Angiotensin II Type 2 Receptor Overexpression Inhibits Tumor Growth of Prostate Cancer In VivoTargeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment.Breast cancer proteome takes more than two to tango on TRAIL: beat them at their own game.Local bone marrow renin-angiotensin system in primitive, definitive and neoplastic haematopoiesis.Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer.AT2R Gene Delivered by Condensed Polylysine Complexes Attenuates Lewis Lung Carcinoma after Intravenous Injection or Intratracheal Spray.Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapy.Overexpression of angiotensin II type 2 receptor promotes apoptosis and impairs insulin secretion in rat insulinoma cells.Recent advances on liposomal nanoparticles: synthesis, characterization and biomedical applications.Effect of lipid headgroup charge and pH on the stability and membrane insertion potential of calcium condensed gene complexes.Combined Local Pulmonary and Systemic Delivery of AT2R Gene by Modified TAT Peptide Nanoparticles Attenuates Both Murine and Human Lung Carcinoma Xenografts in Mice.Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy.Lack of association between ACE insertion/deletion polymorphism and lung cancer: A meta-analysis.Nanoparticles co-delivering pVSVMP and pIL12 for synergistic gene therapy of colon cancer
P2860
Q26795943-B65EAB45-FDB4-40E9-930F-EF005CC4B498Q27023787-BC81B3AF-9751-4054-8CE1-15C2744C8BC3Q33577737-FAF25494-B2B2-4959-874F-F99A6D74C102Q33784943-A2C8C6AF-9C14-4BEA-ACD0-E4003264340DQ34110128-6EF5E174-76C5-4119-8E24-262DFDDD57C4Q34747045-CE1DEA19-9509-4BB1-87D1-31315854933BQ35082610-94B5D802-0489-49BD-99AD-8B6EE2FB925AQ35089791-C39EFE34-238A-41FA-9FE8-2A517F15D69BQ35127888-5D3D00EA-C930-44E8-9935-9BDEC36A730CQ36321710-BE5B31C8-B81F-4ED7-98BB-67D73FCA461AQ36400573-AA8732F6-1439-4F9D-A299-4DAD056A5CD7Q36473924-9978F966-68FE-4D86-91DC-F068FF02DF65Q37580230-615DA7F6-08E7-4CB3-9ED3-88FFCF373598Q38035209-0E930785-29DB-4277-A6B3-52D4A583CD6BQ38060210-CEA186D7-8352-4154-A5F5-2CAFBECEDEC7Q38125505-C6CB2439-3CCF-4296-9DD1-165E0CF0B7BFQ38814333-4B9BB597-6991-49B9-B797-F928804259C8Q38923010-DB7A1B29-ABEA-4D75-99FD-9FE247596B23Q38937272-96B9C1ED-7971-4C6B-A8A4-B3B31D8AF29CQ39171230-4399B809-32DF-428B-92F8-C6F6F60D6A93Q41229373-4ABFC0E2-FEA6-4D4E-B64A-2819EF7996AAQ45861165-0F293EFB-9006-44DB-9ACD-0D3E0BE47B21Q50070105-CEC5CE33-2C7E-473B-8A93-EF70B937DA7DQ51706186-A7C8AE73-C226-4322-8F25-C019EC87385CQ58006187-B1251FDA-D339-4AFC-AAD2-8752223203C3
P2860
Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Intratracheal administration o ...... attenuates lung cancer growth.
@ast
Intratracheal administration o ...... attenuates lung cancer growth.
@en
type
label
Intratracheal administration o ...... attenuates lung cancer growth.
@ast
Intratracheal administration o ...... attenuates lung cancer growth.
@en
prefLabel
Intratracheal administration o ...... attenuates lung cancer growth.
@ast
Intratracheal administration o ...... attenuates lung cancer growth.
@en
P2093
P2860
P1433
P1476
Intratracheal administration o ...... attenuates lung cancer growth.
@en
P2093
Abdulgader Baoum
Atsushi Kawabata
Cory Berkland
Gwi-Moon Seo
Masaaki Tamura
Stephanie Jacquez
P2860
P304
P356
10.1158/0008-5472.CAN-11-3634
P407
P50
P577
2012-03-02T00:00:00Z